Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IP6K1 | Q92551 | 1/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26527274 | 0.93 | GABRA5 (0.32) | GABRA5PIK3CA | |
| SCHEMBL26527318 | 0.93 | CFTR (0.32) | GABRA5 | |
| SCHEMBL25116475 | 0.92 | IP6K1 (0.32) | IP6K1GABRA5PIK3CA | |
| SCHEMBL25116376 | 0.92 | IP6K1 (0.31) | IP6K1GABRA5PIK3CA | |
| SCHEMBL25116312 | 0.92 | IP6K1 (0.31) | IP6K1GABRA5PIK3CA | |
| SCHEMBL23905261 | 0.92 | PIK3CA (0.32) | IP6K1GABRA5PIK3CA | |
| SCHEMBL24984882 | 0.92 | PIK3CA (0.32) | IP6K1GABRA5PIK3CA | |
| SCHEMBL24984881 | 0.92 | PIK3CA (0.32) | IP6K1GABRA5PIK3CA | |
| SCHEMBL25116469 | 0.92 | IP6K1 (0.32) | IP6K1GABRA5PIK3CA | |
| SCHEMBL25116542 | 0.92 | IP6K1 (0.31) | IP6K1GABRA5PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230125803-A1 | ANTIVIRAL HETEROCYCLIC COMPOUNDS | ENANTA PHARM INC (US) | 2023-04-27 | — | — | US | disclosed |
| US-20230125803-A1 | ANTIVIRAL HETEROCYCLIC COMPOUNDS | ENANTA PHARM INC (US) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230125803-A1 | ANTIVIRAL HETEROCYCLIC COMPOUNDS | ACE, HPRT1, ACE2 | IP6K1 2026/4885GABRA5 3773/4885PIK3CA 1428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.